1. Barak V, Goike H, Panaretakis KW, Einarsson R. Clinical utility of cytokeratins as tumor markers. Clin Biochem. 2004; 37(7):529–40. https://doi.org/10.1016/j.clinbiochem.2004.05.009 PMID: 15234234.
2. Brembeck FH, Moffett J, Wang TC, Rustgi AK. The keratin 19 promoter is potent for cell-specific target- ing of genes in transgenic mice. Gastroenterology. 2001; 120(7):1720–8. https://doi.org/10.1053/gast. 2001.24846 PMID: 11375953.
3. Asfaha S, Hayakawa Y, Muley A, Stokes S, Graham TA, Ericksen RE, et al. Krt19(+)/Lgr5(-) Cells Are Radioresistant Cancer-Initiating Stem Cells in the Colon and Intestine. Cell Stem Cell. 2015; 16(6):627–38. https://doi.org/10.1016/j.stem.2015.04.013 PMID: 26046762.
4. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002; 40 (5):403–39. PMID: 12010363.
5. Jain R, Fischer S, Serra S, Chetty R. The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver. Appl Immunohistochem Mol Morphol. 2010; 18(1) :9–15. https://doi.org/10.1097/PAI.0b013e3181ad36ea PMID: 19956064.
6. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, et al. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J. 1999; 18(21):5931–42. https://doi.org/10. 1093/emboj/18.21.5931 PMID: 10545105.
7. Zhao GF, Zhao S, Liu JJ, Wu JC, He HY, Ding XQ, et al. Cytokeratin 19 promoter directs the expression of Cre recombinase in various epithelia of transgenic mice. Oncotarget. 2017; 8(11):18303–11. Epub 2017/04/15. https://doi.org/10.18632/oncotarget.15435 PMID: 28407687.
8. Means AL, Xu Y, Zhao A, Ray KC, Gu G. A CK19(CreERT) knockin mouse line allows for conditional DNA recombination in epithelial cells in multiple endodermal organs. Genesis. 2008; 46(6):318–23. https://doi.org/10.1002/dvg.20397 PMID: 18543299.
9. Shimshek DR, Kim J, Hubner MR, Spergel DJ, Buchholz F, Casanova E, et al. Codon-improved Cre recombinase (iCre) expression in the mouse. Genesis. 2002; 32(1):19–26. PMID: 11835670.
10. Bridges PJ, Koo Y, Kang DW, Hudgins-Spivey S, Lan ZJ, Xu X, et al. Generation of Cyp17iCre trans- genic mice and their application to conditionally delete estrogen receptor alpha (Esr1) from the ovary and testis. Genesis. 2008; 46(9):499–505. https://doi.org/10.1002/dvg.20428 PMID: 18781648.
11. Cacioppo JA, Koo Y, Lin PC, Gal A, Ko C. Generation and characterization of an endothelin-2 iCre mouse. Genesis. 2015; 53(2):245–56. https://doi.org/10.1002/dvg.22845 PMID: 25604013.
12. Cacioppo JA, Koo Y, Lin PC, Osmulski SA, Ko CD, Ko C. Generation of an estrogen receptor beta-iCre knock-in mouse. Genesis. 2016; 54(1):38–52. https://doi.org/10.1002/dvg.22911 PMID: 26663382.
13. Park CJ, Chen G, Koo Y, Lin PP, Cacioppo JA, Prohaska H, et al. Generation and characterization of an estrogen receptor alpha-iCre knock-in mouse. Genesis. 2017. https://doi.org/10.1002/dvg.23084 PMID: 29115049.
14. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, Court DL, et al. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics. 2001; 73(1):56–65. https://doi.org/10.1006/geno.2000.6451 PMID: 11352566.
15. Liu P, Jenkins NA, Copeland NG. A highly efficient recombineering-based method for generating condi- tional knockout mutations. Genome Res. 2003; 13(3):476–84. https://doi.org/10.1101/gr.749203 PMID: 12618378.
16. Testa G, Zhang Y, Vintersten K, Benes V, Pijnappel WW, Chambers I, et al. Engineering the mouse genome with bacterial artificial chromosomes to create multipurpose alleles. Nat Biotechnol. 2003; 21(4):443–7. https://doi.org/10.1038/nbt804 PMID: 12627172.
17. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG. Simple and highly efficient BAC recom- bineering using galK selection. Nucleic Acids Res. 2005; 33(4):e36. https://doi.org/10.1093/nar/gni035 PMID: 15731329.
18. Thomason LC, Sawitzke JA, Li X, Costantino N, Court DL. Recombineering: genetic engineering in bac- teria using homologous recombination. Curr Protoc Mol Biol. 2014; 106:1 16 1–39. https://doi.org/10.1002/0471142727.mb0116s106 PMID: 24733238.
19. Gebhard S, Hattori T, Bauer E, Bosl MR, Schlund B, Poschl E, et al. BAC constructs in transgenic reporter mouse lines control efficient and specific LacZ expression in hypertrophic chondrocytes under the complete Col10a1 promoter. Histochem Cell Biol. 2007; 127(2):183–94. https://doi.org/10.1007/ s00418-006-0236-8 PMID: 17051351.
20. Ting JT, Feng G. Recombineering strategies for developing next generation BAC transgenic tools for optogenetics and beyond. Front Behav Neurosci. 2014; 8:111. https://doi.org/10.3389/fnbeh.2014. 00111 PMID: 24772073.
21. Chandler KJ, Chandler RL, Broeckelmann EM, Hou Y, Southard-Smith EM, Mortlock DP. Relevance of BAC transgene copy number in mice: transgene copy number variation across multiple transgenic lines and correlations with transgene integrity and expression. Mamm Genome. 2007; 18(10):693–708. Epub 2007/09/21. https://doi.org/10.1007/s00335-007-9056-y PMID: 17882484.
22. Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010; 13(1):133–40. https://doi.org/10.1038/nn.2467 PMID: 20023653.
23. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet. 1999; 21(1) :70–1. https://doi.org/10.1038/5007 PMID: 9916792.
24. Wang F, Flanagan J, Su N, Wang LC, Bui S, Nielson A, et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 2012; 14(1):22–9. https://doi.org/ 10.1016/j.jmoldx.2011.08.002 PMID: 22166544.
25. Stempel AJ, Morgans CW, Stout JT, Appukuttan B. Simultaneous visualization and cell-specific confir- mation of RNA and protein in the mouse retina. Mol Vis. 2014; 20:1366–73. Epub 2014/10/30. PMID: 25352743.
26. Tamai Y, Ishikawa T, Bosl MR, Mori M, Nozaki M, Baribault H, et al. Cytokeratins 8 and 19 in the mouse placental development. J Cell Biol. 2000; 151(3):563–72. https://doi.org/10.1083/jcb.151.3.563 PMID: 11062258.
27. Means AL, Chytil A, Moses HL, Coffey RJ Jr., Wright CV, Taketo MM, et al. Keratin 19 gene drives Cre recombinase expression throughout the early postimplantation mouse embryo. Genesis. 2005; 42(1) :23–7. https://doi.org/10.1002/gene.20119 PMID: 15828001.